New technique shields healthy liver during cancer radiation
NCT ID NCT06229080
First seen Feb 13, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study tested a method to protect healthy parts of the liver during a radiation treatment called Y90 radioembolization for liver cancer. Doctors used temporary gelatin sponge particles to block blood flow to healthy liver areas, aiming to keep radiation away from them. The study involved 20 adults with primary or metastatic liver cancer who were good candidates for this treatment. The goal was to see if this approach could safely reduce radiation damage to healthy tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER (PRIMARY AND METASTATIC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea
Conditions
Explore the condition pages connected to this study.